P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer.
Bates M, Mullen D, Lee E, Costigan D, Heron EA, Kernan N, Barry-O'Crowley J, Martin C, Keegan H, Malone V, Brooks RD, Brooks DA, Logan JM, Martini C, Selemidis S, McFadden J, O'Riain C, Spillane CD, Gallagher MF, McCann A, O'Toole S, O'Leary JJ.
Bates M, et al. Among authors: martin c.
Pathol Res Pract. 2024 Jan;253:155020. doi: 10.1016/j.prp.2023.155020. Epub 2023 Dec 7.
Pathol Res Pract. 2024.
PMID: 38103365
Free article.